The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 24, 2021

Filed:

Apr. 04, 2014
Applicants:

The Administrators of the Tulane Educational Fund, New Orleans, LA (US);

Xavier University of Louisiana, New Orleans, LA (US);

The United States of America, As Represented BY the Secretary of Agriculture, Washington, DC (US);

Inventors:

Amy Strong, New Orleans, LA (US);

Stephen Boue, Washington, DC (US);

Matthew Burow, New Orleans, LA (US);

Bruce Bunnell, New Orleans, LA (US);

Quan Jiang, New Orleans, LA (US);

Shilong Zheng, New Orleans, LA (US);

Guangdi Wang, New Orleans, LA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 493/04 (2006.01); A61K 31/352 (2006.01); A61K 35/28 (2015.01); C07D 311/36 (2006.01); A61K 45/06 (2006.01); A61L 27/54 (2006.01); C07D 311/04 (2006.01);
U.S. Cl.
CPC ...
C07D 493/04 (2013.01); A61K 31/352 (2013.01); A61K 35/28 (2013.01); A61K 45/06 (2013.01); A61L 27/54 (2013.01); C07D 311/04 (2013.01); C07D 311/36 (2013.01); A61L 2300/412 (2013.01); A61L 2430/02 (2013.01);
Abstract

Disclosed are daidzein analogs having the formula (I). Also disclosed are compositions, include a disclosed daidzein analogs, methods of preventing or treating bone disease or bone injury and/or stimulating bone growth, in a subject that include administering to the subject an effective amount of disclosed daidzein analog. Disclosed are isolated mesenchymal stem cell that has been altered by treatment a disclosed daidzein analog, daidzein, glycinol, glyceollin I, or glyceollin II, to increase the osteogenic potential of the mesenchymal stem cells.


Find Patent Forward Citations

Loading…